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Table. Markers of atherosclerosis in relation to prevalent knee OA, stratiﬁed by
gender
Knee OA (Women) OR (95% CI)* Knee OA (Men) OR (95% CI)*
Coronary artery
calciﬁcation
1.11 (0.95–1.30) 1.11 (0.86–1.43)
CD40L 1.32 (1.12–1.56)** 1.05 (0.80–1.37)
VCAM-1 1.31 (1.08–1.59)** 1.08 (0.82–1.42)
VEG-f 1.08 (0.93–1.24) 1.07 (0.90–1.28)
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Purpose: Several observational studies have found an association
between subclinical measures of atherosclerosis and osteoarthritis
(OA) of the hands and knees, predominantly among women. Dif-
ferent mechanisms have been suggested to explain the potential
relation between atherosclerosis and OA; systemic low-grade
inﬂammation caused by visceral adipose tissue is particularly men-
tioned and may consequently highlight a route to improve pre-
vention and treatment of atherosclerosis and OA. However, the
reported associations between subclinical measures of athero-
sclerosis and OA were modest in effect size, derived mainly from
cross-sectional studies and generally attenuated after adjustment for
cardiovascular risk factors. Furthermore, previous results were
inconsistent for the different imaging markers of atherosclerosis. In
previous work, we found no relation between peripheral measure-
ments of atherosclerosis (including carotid intima-media-thickness
or carotid plaque) and progression of knee, hand, or hip OA in a
large sample of a prospective cohort study. Hence, it remains unclear
whether atherosclerosis and OA are related or whether they aresimply independent disorders with shared risk factors. Coronary
artery calciﬁcation (CAC) is considered a late stage pathognomonic
feature of coronary atherosclerosis. CD40L, VCAM-1, and VEG-f are
serum biomarkers that reﬂect initial inﬂammatory stages of vascular
wall damage in the ischemic cascade. In the vascular endothelium,
VEG-f is a protein that stimulates angiogenesis, CD-40L and VCAM-1
are molecules that initiate coagulation and immune responses. We
therefore investigated the association between these markers of
early and late atherosclerosis and presence and progression of knee
OA, a possible cardiometabolic phenotype of OA, in a large pop-
ulation-based cohort study.
Methods: The analyses on prevalence of knee OA were performed in
3,465 participants from the prospective population-based Rotterdam
Study (mean age 73.1 years, 61% women). Data on coronary artery
calciﬁcation (CAC) were available for 1,669 participants and plasma
levels of CD40L, VCAM-1, and VEG-f in 975. For the analyses on
progression of knee OA, data on CAC was available for 979 partic-
ipants (17% progressors), and 246 participants (20% progressors) had
plasma levels of CD40L, VCAM-1, and VEG-f. We scored radiographs
of the knee with the Kellgren-Lawrence (K&L) score for osteoarthritis
(knee OA present with a K&L graded score greater or equal to 2) at
baseline and follow-up (average follow-up time 4.5 years (0.5)).
Overall progression of knee OA was deﬁned as the combination of
the incidence and the progression of existing OA at baseline and was
considered present if the K&L score increased 1 grade between
baseline and follow-up visit. After stratiﬁcation by gender, multi-
variate logistic regression models with generalized estimated equa-
tions on knee level were used to calculate odds ratios (95%
conﬁdence intervals) for prevalence and progression of knee OA per
each SD increase in marker levels.
Results: Within the study population, 18% had radiographic knee OA,
11% of the men, 23% of the women. CAC and VEG-f were not associated
with prevalent knee OA. Among women, CD40L (adjusted odds ratio
(aOR) 1.31 (1.12 to 1.56)) and VCAM-1 (aOR 1.31 (1.08 to 1.59)) were
associated with prevalent knee OA (table). No associations with pro-
gression were found in women. In men, too few progressors were
available to assess associations.Conclusions: In this population-based study, coronary artery calciﬁ-
cation and VEG-f were not associated with presence or progression of
knee OA. However, plasma levels of CD40L and VCAM-1 were higher in
women with knee OA and not in men. This might reﬂect an association
between early atherosclerosis and knee OA through low-grade systemic
inﬂammation in women.
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MECHANISMS INVOLVED IN INHIBITION OF INFLAMMATION IN
THP-1 CELLS BY THE HEXADECYLAMIDE DERIVATIVE OF
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Purpose: Intra-articular injections of hyaluronic acid are widely used in
the treatment of inﬂammatory and degenerative joint diseases. The
immune regulation exerted by hyaluronic acid is modulated by its
interaction with different receptors including CD44 and the toll-like
receptors 2 and 4. A novel hexadecylamide derivative of hyaluronic acid
(HA), HYADD4, has recently been tested in animal models of osteo-
arthritis, showing both anti-inﬂammatory and anabolic effects. The
purpose of this study is to investigate the possiblemechanisms involved
on the effect of unmodiﬁed and hexadecylamide derivative
